Literature DB >> 29234197

Echocardiographic and Electrocardiographic Predictors of Adverse Outcomes in Spontaneous Bacterial Peritonitis.

Mahek Shah1, Soumya Patnaik2, Obiora Maludum2, Shantanu Patil2, Toni Anne De Venecia2, Vincent M Figueredo3,4.   

Abstract

BACKGROUND: Patients with cirrhosis who develop Spontaneous Bacterial Peritonitis (SBP) suffer from cirrhotic cardiomyopathy which is characterized by impaired contractility in response to stress despite a relatively normal resting cardiac output. We hypothesized that electrocardiographic and echocardiographic information would help prognosticate patients developing SBP in addition to existing scoring systems.
METHODS: Cirrhotic patients admitted to Einstein Medical Center from 01/01/2005 to 6/30/2012 for SBP, and did not receive a transplant within one year, were included. Patients were classified as QTc low vs. high, and E/E' low vs. high at cut points ≥480 ms for QTc and ≥10 for E/E' ratio. We estimated 1-year survival using Kaplan Meier curves. Regression analysis and Cox proportional hazards model were used for QTc and E/E' ratio, respectively, for assessing 1-year survival.
RESULTS: Among 112 patients with electrocardiogam, 78 were classified as QTc low. Among 64 patients with echocardiograms, 23 were classified as E/E' low. Higher QTc was associated with increased in-hospital acute kidney injury. QTc and E/E' ratio predicted worse 1-year survival (HR = 2.16, 95% CI 1.29-3.49; HR 2.65, 95% CI 1.31-5.35, respectively) on univariate and multivariate analysis (OR = 1.02, 95% CI 1.01-1.03; HR = 3.26, 95% CI 1.22-9.82 respectively) after adjusting for both Child Pugh stage, MELD score among other risk factors.
CONCLUSION: In conclusion, cirrhotic patients with SBP who present with a prolonged QTc interval are at a greater risk for acute renal failure during hospitalization. High QTc duration and an E/E' ratio of ≥10 independently predict increased mortality at 1-year follow-up.

Entities:  

Keywords:  ARF, acute renal failure; CPS, Child–Pugh score; E/E′ ratio; MELD, Model for End Stage Liver Disease; QTc; cirrhotic cardiomyopathy; diastolic dysfunction; echocardiography; spontaneous bacterial peritonitis

Year:  2017        PMID: 29234197      PMCID: PMC5715479          DOI: 10.1016/j.jceh.2017.05.007

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  38 in total

1.  A study of heart disease in one hundred eight hospitalized patients dying with portal cirrhosis.

Authors:  J H LUNSETH; E G OLMSTEAD; F ABBOUD
Journal:  AMA Arch Intern Med       Date:  1958-09

2.  Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death.

Authors:  Douglas M Heuman; Souheil G Abou-Assi; Adil Habib; Leslie M Williams; R Todd Stravitz; Arun J Sanyal; Robert A Fisher; Anastasios A Mihas
Journal:  Hepatology       Date:  2004-10       Impact factor: 17.425

Review 3.  Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD.

Authors:  François Durand; Dominique Valla
Journal:  J Hepatol       Date:  2004-12-24       Impact factor: 25.083

Review 4.  The sympathetic nervous system in liver disease.

Authors:  J H Henriksen; S Møller; H Ring-Larsen; N J Christensen
Journal:  J Hepatol       Date:  1998-08       Impact factor: 25.083

Review 5.  Surgery and portal hypertension.

Authors:  C G Child; J G Turcotte
Journal:  Major Probl Clin Surg       Date:  1964

6.  Impaired responsiveness to angiotensin II in experimental cirrhosis: role of nitric oxide.

Authors:  A Castro; W Jiménez; J Clària; J Ros; J M Martínez; M Bosch; V Arroyo; J Piulats; F Rivera; J Rodés
Journal:  Hepatology       Date:  1993-08       Impact factor: 17.425

7.  Spontaneous bacterial peritonitis in asymptomatic outpatients with cirrhotic ascites.

Authors:  Luke T Evans; W Ray Kim; John J Poterucha; Patrick S Kamath
Journal:  Hepatology       Date:  2003-04       Impact factor: 17.425

8.  Diastolic dysfunction is associated with poor survival in patients with cirrhosis with transjugular intrahepatic portosystemic shunt.

Authors:  Massimo Cazzaniga; Francesco Salerno; Giovanni Pagnozzi; Elena Dionigi; Stefania Visentin; Ilaria Cirello; Daniele Meregaglia; Antonio Nicolini
Journal:  Gut       Date:  2006-11-29       Impact factor: 23.059

Review 9.  A model to predict survival in patients with end-stage liver disease.

Authors:  P S Kamath; R H Wiesner; M Malinchoc; W Kremers; T M Therneau; C L Kosberg; G D'Amico; E R Dickson; W R Kim
Journal:  Hepatology       Date:  2001-02       Impact factor: 17.425

10.  Two-dimensional and dobutamine stress echocardiography in the preoperative assessment of patients with end-stage liver disease prior to orthotopic liver transplantation.

Authors:  C L Donovan; P A Marcovitz; J D Punch; D S Bach; K A Brown; M R Lucey; W F Armstrong
Journal:  Transplantation       Date:  1996-04-27       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.